4//SEC Filing
Grossi Federico 4
Accession 0000899243-22-037437
CIK 0001492422other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:30 PM ET
Size
4.8 KB
Accession
0000899243-22-037437
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-12-01$49.93/sh−2,500$124,825→ 97,384 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2022.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720634
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:30 PM ET
- Size
- 4.8 KB